No substantial benefit from transplantation reported for a high-risk leukaemia subtype
Checking for minimal residual disease early in treatment can help some young high-risk leukaemia patients…
Browsing: Leukaemia
New leukaemia drug is more effective and easier to use
A landmark study co-authored by a Loyola Medicine oncologist has found that a newer targeted…
An errant editing enzyme promotes tumour suppressor loss and leukaemia propagation
Writing in the journal Cancer Cell, researchers at University of California San Diego School of Medicine…
ASH 2018: Ibrutinib outperforms chemoimmunotherapy in older patients with chronic lymphocytic leukaemia
A new study presented at ASH 2018 shows older patients with chronic lymphocytic leukaemia (CLL) have a…
ASH 2018: Rapid genetic screening shows feasibility of precision medicine for acute myeloid leukaemia
A new study presented at ASH 2018 in San Diego demonstrates it is feasible – and helpful…
Major breakthrough in quest for cancer vaccine
The idea of a cancer vaccine is something researchers have been working on for over…
ASH 2018: New research on stem cell transplantation for myeloid cancers
Improving outcomes for patients with myeloid cancers who undergo stem cell transplantation was the focus…
91 percent response rate for venetoclax against newly diagnosed AML in older adults
Clinical trial results published in the journal Nature Medicine show 91 percent response rate to the combination…
What it means when scientists say their results are ‘significant’
Yazad Irani, South Australian Health & Medical Research Institute Let’s face it, scientific papers aren’t…
First of its kind research models immune responses in cellular immunotherapies
In the Cellular Immunotherapy and Transplantation Program at Virginia Commonwealth University Massey Cancer Center, scientists…